当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 现金流量表

华兰生物

(002007)

  

流通市值:228.75亿  总市值:265.71亿
流通股本:15.73亿   总股本:18.27亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金819,616,146.734,451,476,719.53,056,450,334.042,017,751,654.45
  收到的税费返还39,179,943.62,333,182.08--
  收到其他与经营活动有关的现金24,077,141.7963,444,684.5349,577,991.2231,682,074.43
  经营活动现金流入小计882,873,232.124,517,254,586.113,106,028,325.262,049,433,728.88
  购买商品、接受劳务支付的现金475,978,555.51,623,341,704.861,201,832,710.1850,392,734.93
  支付给职工以及为职工支付的现金152,873,951.85498,704,992.81376,796,113.02259,013,142.67
  支付的各项税费135,377,471.06398,199,167.11295,882,306.07196,142,364.45
  支付其他与经营活动有关的现金125,032,833.141,119,052,221.08780,888,381.48513,378,528.05
  经营活动现金流出小计889,262,811.553,639,298,085.862,655,399,510.671,818,926,770.1
  经营活动产生的现金流量净额-6,389,579.43877,956,500.25450,628,814.59230,506,958.78
二、投资活动产生的现金流量:
  收回投资收到的现金2,601,724,646.2912,224,906,537.789,476,763,328.537,405,875,686.75
  取得投资收益收到的现金76,856,763.87264,014,024.63195,988,242.7196,651,869.89
  处置固定资产、无形资产和其他长期资产收回的现金净额69,782.622,685,413.56480,068.6542,792
  投资活动现金流入小计2,678,651,192.7812,491,605,975.979,673,231,639.897,502,570,348.64
  购建固定资产、无形资产和其他长期资产支付的现金51,713,943.75197,305,265.37148,340,438.42112,188,844.68
  投资支付的现金2,063,000,00011,760,017,908.48,788,517,908.46,882,517,908.4
  支付其他与投资活动有关的现金---12,840
  投资活动现金流出小计2,114,713,943.7511,957,323,173.778,936,858,346.826,994,719,593.08
  投资活动产生的现金流量净额563,937,249.03534,282,802.2736,373,293.07507,850,755.56
三、筹资活动产生的现金流量:
  取得借款收到的现金-724,942,840.01724,405,900.01278,159,999.98
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-724,942,840.01724,405,900.01278,159,999.98
  偿还债务支付的现金447,000,0001,179,380,0001,179,380,000819,380,000
  分配股利、利润或偿付利息支付的现金-1,528,602,067.26390,198,653.05386,700,910.7
  其中:子公司支付给少数股东的股利、利润-167,120,026.456,360,006.656,360,006.6
  支付其他与筹资活动有关的现金-14,023,913.414,023,913.414,023,913.4
  筹资活动现金流出小计447,000,0002,722,005,980.661,583,602,566.451,220,104,824.1
  筹资活动产生的现金流量净额-447,000,000-1,997,063,140.65-859,196,666.44-941,944,824.12
四、汇率变动对现金及现金等价物的影响-80,561.38140,062.36175,338.16189,692.01
五、现金及现金等价物净增加额110,467,108.22-584,683,775.84327,980,779.38-203,397,417.77
  加:期初现金及现金等价物余额773,576,445.841,358,260,221.681,358,260,221.681,358,260,221.68
  期末现金及现金等价物余额884,043,554.06773,576,445.841,686,241,001.061,154,862,803.91
补充资料:
  净利润-999,992,847.58-522,691,390.04
  资产减值准备-58,207,765.52--12,277,453.7
  固定资产和投资性房地产折旧-262,512,275.03-130,752,182.59
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-262,512,275.03-130,752,182.59
  无形资产摊销-12,439,838.81-6,096,426.39
  长期待摊费用摊销-6,026,473.54-2,944,181.02
  处置固定资产、无形资产和其他长期资产的损失--2,891,234.85-21,450.45
  固定资产报废损失-3,527,237.33-1,464,932.24
  公允价值变动损失--15,171,586.8--12,504,878.82
  财务费用-10,000,229.83-4,560,270.78
  投资损失--62,497,631.37--78,427,996.02
  递延所得税-6,457,511.49--8,544,518.86
  其中:递延所得税资产减少-38,487,550.47--8,608,932.01
    递延所得税负债增加--32,030,038.98-64,413.15
  存货的减少--317,321,310.24--262,647,350.4
  经营性应收项目的减少--423,098,940.65-378,167,420.25
  经营性应付项目的增加-333,297,801.22--413,062,669.54
  其他--27,966,491.88-5,527,310.88
  现金的期末余额-773,576,445.84-1,154,862,803.91
  减:现金的期初余额-1,358,260,221.68-1,358,260,221.68
  现金及现金等价物的净增加额--584,683,775.84--203,397,417.77
公告日期2026-04-272026-03-282025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑